DEEP EXPERIENCE. SHARED COMMITMENT.
"We take a private equity approach to a sector that’s traditionally been dominated by venture and early-stage growth firms. We'll work very closely with management to improve the operations of the business, update the product portfolio and revamp the commercial organization. We provide the support and resources our portfolio companies need to succeed.”
19
active portfolio companies
+
1200
employees worldwide
3
AP-II Investments to Date
9
successful exits
news
Oct 22, 2021
Accelmed and H.I.G. BioHealth Co-Lead $52 Million Series B for Click Therapeutics
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed a $52 million upsized Series B financing
Sep 14, 2021
Accelmed announces hiring of Katherine Relle as Vice PresidentAccelmed Partners announced Katherine Relle has joined the firm as Vice President from J.P. Morgan’s Private Equity Group.
Sep 01, 2021
Keystone Dental acquires Osteon Medical, raises $25m led by NantahalaAccelmed Partners I portfolio company Keystone Dental Inc. announced the acquisition of Osteon Medical and the completion of a $25 million financing round led by Nantahala, with participation from Accelmed and Migdal Insurance.
Aug 30, 2021
CartiHeal to be acquired by Bioventus for $500 millionAccelmed Ventures portfolio company CartiHeal is being acquired by Bioventus for $350 million in upfront consideration and up to $500 million including earn-outs.
Contact Us